A randomized, double-blind, placebo-controlled trial is conducted to evaluate the efficacy of a novel lipid-lowering medication in preventing myocardial infarction in high-risk patients. A total of 2,000 patients are enrolled and equally randomized to receive either the new medication or a placebo. Over a 5-year follow-up period, 50 out of the 1,000 patients in the treatment group experience a myocardial infarction. In the placebo group, 100 out of the 1,000 patients experience a myocardial infarction. Based on these findings, what is the number needed to treat with the new medication to prevent one additional myocardial infarction over 5 years?
- A2
- B10
- 20Cevap
- D50
- E100
Cevap
20
The correct answer is 20 because the Number Needed to Treat (NNT) is the inverse of the Absolute Risk Reduction (ARR). The ARR is the control event rate () minus the experimental event rate (), which equals . Therefore, .
Adım Adım Çözüm
Anahtar Kavram
The Number Needed to Treat (NNT) is calculated as , where Absolute Risk Reduction (ARR) is the difference between the control event rate and the experimental event rate.
Tahmini Süre:45s